Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance.

MLA

Lyu, Junhua, et al. “Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance.” Cancer Discovery, vol. 13, no. 1, Jan. 2023, pp. 170–93. EBSCOhost, https://doi.org/10.1158/2159-8290.CD-21-1661.

APA

Lyu, J., Liu, Y., Gong, L., Chen, M., Madanat, Y. F., Zhang, Y., Cai, F., Gu, Z., Cao, H., Kaphle, P., Kim, Y. J., Kalkan, F. N., Stephens, H., Dickerson, K. E., Ni, M., Chen, W., Patel, P., Mims, A. S., Borate, U., … Xu, J. (2023). Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance. Cancer Discovery, 13(1), 170–193. https://doi.org/10.1158/2159-8290.CD-21-1661

Chicago

Lyu, Junhua, Yuxuan Liu, Lihu Gong, Mingyi Chen, Yazan F Madanat, Yuannyu Zhang, Feng Cai, et al. 2023. “Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance.” Cancer Discovery 13 (1): 170–93. doi:10.1158/2159-8290.CD-21-1661.